RT Journal Article
SR Electronic
T1 Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 1495
OP 1503
DO 10.2967/jnumed.120.261016
VO 62
IS 11
A1 Radchenko, Valery
A1 Morgenstern, Alfred
A1 Jalilian, Amir R.
A1 Ramogida, Caterina F.
A1 Cutler, Cathy
A1 Duchemin, Charlotte
A1 Hoehr, Cornelia
A1 Haddad, Ferrid
A1 Bruchertseifer, Frank
A1 Gausemel, Haavar
A1 Yang, Hua
A1 Osso, Joao Alberto
A1 Washiyama, Kohshin
A1 Czerwinski, Kenneth
A1 Leufgen, Kirsten
A1 Pruszyński, Marek
A1 Valzdorf, Olga
A1 Causey, Patrick
A1 Schaffer, Paul
A1 Perron, Randy
A1 Maxim, Samsonov
A1 Wilbur, D. Scott
A1 Stora, Thierry
A1 Li, Yawen
YR 2021
UL http://jnm.snmjournals.org/content/62/11/1495.abstract
AB Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.